Plazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae.
McKinnell, James A; Dwyer, Jamie P; Talbot, George H; Connolly, Lynn E; Friedland, Ian; Smith, Alex; Jubb, Adrian M; Serio, Alisa W; Krause, Kevin M; Daikos, George L.
N Engl J Med
; 380(8): 791-793, 2019 02 21.
Artigo em Inglês | MEDLINE | ID: mdl-30786196
Once-Daily Plazomicin for Complicated Urinary Tract Infections.
Plazomicin is effective in a non-human primate pneumonic plague model.
Plazomicin activity against polymyxin-resistant Enterobacteriaceae, including MCR-1-producing isolates.
Interaction of drug- and granulocyte-mediated killing of Pseudomonas aeruginosa in a murine pneumonia model.
AmpC ß-lactamase-producing Enterobacterales: what a clinician should know.
Multidrug-Resistant Gram-Negative Bacterial Infections in the Hospital Setting: Overview, Implications for Clinical Practice, and Emerging Treatment Options.
The relative importance of large problems far away versus small problems closer to home: insights into limiting the spread of antimicrobial resistance in England.
Comparative study of three routes of administration of sisomicin.
Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by Enterobacter, Citrobacter or Serratia species: a systematic review with meta-analysis.
Bacteremia due to Citrobacter braakii: A case report and literature review.